1. Semenova, A. E., Sergienko, I. V., & Gabrusenko, S. A. (2008). Ob»ektivnye metody ocenki koronarnogo angiogeneza [Objective methods of assessing coronary angiogenesis]. kardiologiya, 48(6), 19-23.

2. Siervo, M., Ruggiero, D., Sorice, R., Nutile, T., Aversano, M., Iafusco, M., ... & Ciullo, M. (2012). Body mass index is directly associated with biomarkers of angiogenesis and inflammation in children and adolescents. Nutrition, 28(3), 262-266.

3. Simó, R., Carrasco, E., García-Ramírez, M., & Hernández, C. (2006). Angiogenic and antiangiogenic factors in proliferative diabetic retinopathy. Current diabetes reviews, 2(1), 71-98.

4. Gómez-Ambrosi, J., Catalán, V., Rodríguez, A., Ramírez, B., Silva, C., Gil, M. J., & Frühbeck, G. (2010). Involvement of serum vascular endothelial growth factor family members in the development of obesity in mice and humans. The Journal of nutritional biochemistry, 21(8), 774- 780.

5. Zorena, K., Myśliwska, J., Myśliwiec, M., Rybarczyk-Kapturska, K., Malinowska, E., Wiśniewski, P., & Raczyńska, K. (2010). Association between vascular endothelial growth factor D.M.Dusmuxamedov, A.A.Yuldashev, D.K.Dusmuxamedova, N.Shamsieva 24 and hypertension in children and adolescents type I diabetes mellitus.Journal of human hypertension, 24(11), 755.

6. Wada, H., Satoh, N., Kitaoka, S., Ono, K., Morimoto, T., Kawamura, T., ... & Hasegawa, K. (2010). Soluble VEGF receptor-2 is increased in sera of subjects with metabolic syndrome in association with insulin resistance. Atherosclerosis, 208(2), 512-517.

7. Ferrara, N., & Davis-Smyth, T. (1997). The biology of vascular endothelial growth factor. Endocrine reviews, 18(1), 4-25.